Med24
metabolic-therapy 19. 10. 2026 • 2 min read • Obesity (Silver Spring, Md.) (PubMed)

Interdisciplinary Weight Management in a Safety-Net Health System: A Pilot Implementation Study.

OBJECTIVE: Despite the high prevalence of obesity and cardiometabolic diseases in safety-net populations, access to intensive, evidence-based lifestyle interventions and scalable implementation strategies remains limited. This study evaluated the effectiveness, acceptability, and feasibility of an interdisciplinary...

Addressing Post-Intensive Care Syndrome Among Survivors of COVID (APICS-COVID)

This study evaluated an interdisciplinary weight management program, LA VIDA, within an urban safety-net health system. The program’s objective was to assess its effectiveness, acceptability, and feasibility for medically complex individuals.

Study Design and Participants

The research utilized a mixed-methods approach to examine outcomes including feasibility, patient engagement, self-rated health, quality of life, physical activity, dietary behaviors, and program satisfaction. Over a two-year period, 95 participants completed the 6-month program. The participants were predominantly female and Latino, with a mean age of 50 years and a median BMI of 39.2. A significant portion of the participants had multiple comorbidities.

Sponsored content

Key Clinical Findings

The program resulted in a median 6-month weight loss of 5.5%. Significant improvements were observed in several areas, including quality of life, physical health, moderate-intensity physical activity, and dietary behaviors. Participants reported high satisfaction with the program, citing personalized guidance, increased health knowledge, mindfulness techniques, and a supportive group environment as key factors. The findings indicate that LA VIDA was feasible and acceptable, leading to improvements in patient-reported behaviors and outcomes within the safety-net setting. These results suggest a model for integrated obesity care combining lifestyle, behavioral, and pharmacologic treatment.

Original Scientific Source
Obesity (Silver Spring, Md.) (PubMed)
View Original Source
Medical Disclaimer All calculations, recommendations, and interpretations provided by this tool are for informational and educational purposes only. They do not substitute professional medical advice, diagnosis, or treatment. Always consult your physician regarding any health concerns.

Recommended Medical News

All news →
Nanotechnology-Driven 18F-FDG Imaging to Understand the Change in Insulin Sensitivity: Current Evidence, Methodological Gaps, and Translational Challenges.
metabolic-therapy

Nanotechnology-Driven 18F-FDG Imaging to Understand the Change in Insulin Sensitivity: Current Evidence, Methodological Gaps, and Translational Challenges.

Insulin resistance is an important metabolic derangement contributing to the pathogenesis of type 2 diabetes, obesity, metabolic syndrome, and other chronic diseases, underlining the requirement for techniques that enable in vivo analysis of tissue-specific glucose metabolism. 18F-fluorodeoxyglucose positron emission...

10. 11. 2026 Read article →
Cardiometabolic Abnormalities among Normal-Weight Adults: Prevalence and Associated Sociodemographic and Lifestyle Factors in a Large Spanish Cohort.
metabolic-therapy

Cardiometabolic Abnormalities among Normal-Weight Adults: Prevalence and Associated Sociodemographic and Lifestyle Factors in a Large Spanish Cohort.

BACKGROUND: Although body mass index (BMI) is widely used to assess obesity-related health risks, it may fail to detect individuals with normal weight who present with significant cardiometabolic abnormalities. This phenotype, often overlooked in clinical practice, is associated with increased risk of cardiovascular...

30. 10. 2026 Read article →
Advertisement